These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3532121

  • 1. "Replacement" of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential.
    Browning PJ, Bunn HF, Cline A, Shuman M, Nienhuis AW.
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7800-4. PubMed ID: 3532121
    [Abstract] [Full Text] [Related]

  • 2. The amino-terminal domain of the v-fms oncogene product includes a functional signal peptide that directs synthesis of a transforming glycoprotein in the absence of feline leukemia virus gag sequences.
    Wheeler EF, Roussel MF, Hampe A, Walker MH, Fried VA, Look AT, Rettenmier CW, Sherr CJ.
    J Virol; 1986 Aug; 59(2):224-33. PubMed ID: 3525854
    [Abstract] [Full Text] [Related]

  • 3. Transforming mechanism of the feline sarcoma virus encoded v-fms oncogene product.
    Tamura T, Hadwiger-Fangmeier A, Simon E, Smola U, Geschwill H, Schütz B, Trouliaris S, Boscheck B, Niemann H, Bauer H.
    Behring Inst Mitt; 1991 Jul; (89):93-9. PubMed ID: 1834054
    [Abstract] [Full Text] [Related]

  • 4. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ.
    Nature; 1991 Jul; 325(6104):549-52. PubMed ID: 3027579
    [Abstract] [Full Text] [Related]

  • 5. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
    Mancini A, Koch A, Wilms R, Tamura T.
    J Biol Chem; 2002 Apr 26; 277(17):14635-40. PubMed ID: 11847211
    [Abstract] [Full Text] [Related]

  • 6. The fms gene and the CSF-1 receptor.
    Sherr CJ, Rettenmier CW.
    Cancer Surv; 1986 Apr 26; 5(2):221-32. PubMed ID: 3022923
    [Abstract] [Full Text] [Related]

  • 7. Colony-stimulating factor 1-mediated regulation of a chimeric c-fms/v-fms receptor containing the v-fms-encoded tyrosine kinase domain.
    Roussel MF, Downing JR, Ashmun RA, Rettenmier CW, Sherr CJ.
    Proc Natl Acad Sci U S A; 1988 Aug 26; 85(16):5903-7. PubMed ID: 2842754
    [Abstract] [Full Text] [Related]

  • 8. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
    Coussens L, Van Beveren C, Smith D, Chen E, Mitchell RL, Isacke CM, Verma IM, Ullrich A.
    Nature; 1988 Aug 26; 320(6059):277-80. PubMed ID: 2421165
    [Abstract] [Full Text] [Related]

  • 9. A new acute transforming feline retrovirus with fms homology specifies a C-terminally truncated version of the c-fms protein that is different from SM-feline sarcoma virus v-fms protein.
    Besmer P, Lader E, George PC, Bergold PJ, Qiu FH, Zuckerman EE, Hardy WD.
    J Virol; 1986 Oct 26; 60(1):194-203. PubMed ID: 3018286
    [Abstract] [Full Text] [Related]

  • 10. The v-fms oncogene induces factor independence and tumorigenicity in CSF-1 dependent macrophage cell line.
    Wheeler EF, Rettenmier CW, Look AT, Sherr CJ.
    Nature; 1986 Oct 26; 324(6095):377-80. PubMed ID: 3024013
    [Abstract] [Full Text] [Related]

  • 11. Reassessment of the v-fms sequence: threonine phosphorylation of the COOH-terminal domain.
    Smola U, Hennig D, Hadwiger-Fangmeier A, Schütz B, Pfaff E, Niemann H, Tamura T.
    J Virol; 1991 Nov 26; 65(11):6181-7. PubMed ID: 1833563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific binding of the mononuclear phagocyte colony-stimulating factor CSF-1 to the product of the v-fms oncogene.
    Sacca R, Stanley ER, Sherr CJ, Rettenmier CW.
    Proc Natl Acad Sci U S A; 1986 May 26; 83(10):3331-5. PubMed ID: 3010289
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oncogenic activation of v-kit involves deletion of a putative tyrosine-substrate interaction site.
    Herbst R, Munemitsu S, Ullrich A.
    Oncogene; 1995 Jan 19; 10(2):369-79. PubMed ID: 7530827
    [Abstract] [Full Text] [Related]

  • 19. Fibroblast and hematopoietic cell transformation by the fms oncogene (CSF-1 receptor).
    Sherr CJ.
    J Cell Physiol Suppl; 1987 Jan 19; Suppl 5():83-7. PubMed ID: 2824535
    [Abstract] [Full Text] [Related]

  • 20. Detection of fms-oncogene-specific tyrosine kinase activity in human leukemia cells.
    Tamura T, Brost H, Käbisch A, Lampert F, Hadwiger-Fangmeier A, Niemann H.
    J Cancer Res Clin Oncol; 1989 Jan 19; 115(3):235-41. PubMed ID: 2526817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.